Corentec Co Ltd
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems,… Read more
Market Cap & Net Worth: Corentec Co Ltd (104540)
Corentec Co Ltd (KQ:104540) has a market capitalization of $51.35 Million (₩75.18 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22195 globally and #1112 in its home market, demonstrating a 5.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Corentec Co Ltd's stock price ₩5880.00 by its total outstanding shares 12785740 (12.79 Million).
Corentec Co Ltd Market Cap History: 2015 to 2026
Corentec Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $130.11 Million to $51.35 Million (-9.11% CAGR).
Index Memberships
Corentec Co Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #528 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #528 of 1384 |
Weight: Corentec Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Corentec Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Corentec Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Corentec Co Ltd's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $130.11 Million | $30.35 Billion | -$859.44 Million | 0.00x | N/A |
| 2016 | $123.56 Million | $35.97 Billion | $466.22 Million | 0.00x | 0.27x |
| 2017 | $102.60 Million | $37.85 Billion | -$7.38 Billion | 0.00x | N/A |
| 2018 | $53.09 Million | $33.41 Billion | -$29.76 Billion | 0.00x | N/A |
| 2019 | $49.16 Million | $40.19 Billion | $2.51 Billion | 0.00x | 0.02x |
| 2021 | $105.66 Million | $44.63 Billion | $763.94 Million | 0.00x | 0.14x |
| 2022 | $94.31 Million | $63.91 Billion | $1.78 Billion | 0.00x | 0.05x |
| 2023 | $103.39 Million | $92.05 Billion | $4.06 Billion | 0.00x | 0.03x |
| 2024 | $44.62 Million | $93.67 Billion | -$2.58 Billion | 0.00x | N/A |
Competitor Companies of 104540 by Market Capitalization
Companies near Corentec Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Corentec Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Corentec Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Corentec Co Ltd's market cap moved from $130.11 Million to $ 51.35 Million, with a yearly change of -9.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩51.35 Million | -12.24% |
| 2025 | ₩58.51 Million | +31.12% |
| 2024 | ₩44.62 Million | -56.84% |
| 2023 | ₩103.39 Million | +9.63% |
| 2022 | ₩94.31 Million | -10.74% |
| 2021 | ₩105.66 Million | +114.92% |
| 2019 | ₩49.16 Million | -7.40% |
| 2018 | ₩53.09 Million | -48.26% |
| 2017 | ₩102.60 Million | -16.96% |
| 2016 | ₩123.56 Million | -5.03% |
| 2015 | ₩130.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Corentec Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.35 Million USD |
| MoneyControl | $51.35 Million USD |
| MarketWatch | $51.35 Million USD |
| marketcap.company | $51.35 Million USD |
| Reuters | $51.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.